Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOFA-PREDICT stratification trial in psoriatic arthritis
2017-003900-28Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tofacitinib in psoriatic arthritis (PsA) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Minimal Disease Activity at week 16. Started Jan 2018; status: active.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2017-003900-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003900-28.